ProfileOfResearchers

Identificadas 25

TÃTULO: Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction A Prespecified Secondary Analysis From the FOURIER Trial
AUTORES: Baris Gencer; Francois Mach; Sabina A Murphy; Gaetano M De Ferrari; Kurt Huber; Basil S Lewis; Jorge Ferreira; Christopher E Kurtz; Huei E Wang; Narimon Honarpour; Anthony C Keech; Peter S Sever; Terje R Pedersen; Marc S Sabatine; Robert P Giugliano;
PUBLICAÇÃO: 2020, FONTE: JAMA CARDIOLOGY, VOLUME: 5, NÚMERO: 8

INDEXADO EM:

Scopus

WOS

TÃTULO: 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
AUTORES: Gregory Y H Lip; Jean Phillippe Collet; Michael Haude; Robert Byrne; Eugene H Chung; Laurent Fauchier; Sigrun Halvorsen; Dennis Lau; Nestor Lopez Cabanillas; Maddalena Lettino; Francisco Marin; Israel Obel; Andrea Rubboli; Robert F Storey; Marco Valgimigli; Kurt Huber; Tatjana Potpara; Carina Blomstrom Lundqvist; Harry Crijns; Jan Steffel; Hein Heidbuchel; Goran Stankovic; Juhani Airaksinen; Jurrien M Ten Berg; Davide Capodanno; Stefan James; Hector Bueno; Joao Morais; Dirk Sibbing; Bianca Rocca; Ming Hsiung Hsieh; Nazem Akoum; Deborah J Lockwood; Jorge Rafael G Gomez Flores; Ronald Jardine; ...Mais
PUBLICAÇÃO: 2019, FONTE: EUROPACE, VOLUME: 21, NÚMERO: 2

INDEXADO EM:

WOS

TÃTULO: Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
AUTORES: Marc S Sabatine; Gaetano M De Ferrari; Robert P Giugliano; Kurt Huber; Basil S Lewis; Jorge Ferreira; Julia F Kuder; Sabina A Murphy; Stephen D Wiviott; Christopher E Kurtz; Narimon Honarpour; Anthony C Keech; Peter S Sever; Terje R Pedersen;
PUBLICAÇÃO: 2018, FONTE: CIRCULATION, VOLUME: 138, NÚMERO: 8

INDEXADO EM:

WOS

TÃTULO: Clinical Benefit of Evolocumab in Patients With a History of MI: An Analysis From FOURIER
AUTORES: Marc S Sabatine; Gaetano M de Ferrari; Robert P Giugliano; Kurt Huber; Basil S Lewis; Jorge Ferreira; Julia F Kuder; Sabina A Murphy; Steven D Wiviott; Christopher Kurtz; Narimon Honarpour; Anthony C Keech; Peter S Sever; Terje R Pedersen;
PUBLICAÇÃO: 2017, FONTE: Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium in CIRCULATION, VOLUME: 136, NÚMERO: 24

INDEXADO EM:

WOS

TÃTULO: Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial
AUTORES: Robert P Giugliano; Anthony Keech; Sabina A Murphy; Kurt Huber; Lale L Tokgozoglu; Basil S Lewis; Jorge Ferreira; Armando Lira Pineda; Ransi Somaratne; Peter S Sever; Terje R Pedersen; Marc S Sabatine;
PUBLICAÇÃO: 2017, FONTE: JAMA CARDIOLOGY, VOLUME: 2, NÚMERO: 12

INDEXADO EM:

WOS

TÃTULO: Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial Full Text
AUTORES: Michael M Lincoff; Roxana Mehran; Thomas J Povsic; Steven L Zelenkofske; Zhen Huang; Paul W Armstrong; Gabriel G Steg; Christoph Bode; Mauricio G Cohen; Christopher Buller; Peep Laanmets; Marco Valgimigli; Toomas Marandi; Viliam Fridrich; Warren J Cantor; Bela Merkely; Jose Lopez Sendon; Jan H Cornel; Jaroslaw D Kasprzak; Michael Aschermann; Victor Guetta; Joao Morais; Peter R Sinnaeve; Kurt Huber; Rod Stables; Mary Ann Sellers; Marilyn Borgman; Lauren Glenn; Arnold I Levinson; Renato D Lopes; Vic Hasselblad; Richard C Becker; John H Alexander; ...Mais
PUBLICAÇÃO: 2016, FONTE: LANCET, VOLUME: 387, NÚMERO: 10016

INDEXADO EM:

Scopus

WOS

CrossRef

TÃTULO: Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
AUTORES: Raffaele De Caterina; Steen Husted; Lars Wallentin; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent; Jean Philippe Collet; Sigrun Halvorsen; Kurt Huber; Jorgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; Joao Morais; Lars Hvilsted Rasmussen; Fabrizio Ricci; Dirk Sibbing; Agneta Siegbahn; Robert F Storey; Jurrien ten Berg; Freek W A Verheugt; Jeffrey I Weitz; ...Mais
PUBLICAÇÃO: 2016, FONTE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 115, NÚMERO: 4

INDEXADO EM:

Scopus

WOS